NCT01380561View on ClinicalTrials.gov

A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Healthy
Interventions
DRUG

asimadoline

10mg \[14\]C labelled asimadoline Day 1 then 7 doses 0.5 mg asimadoline bid beginning on Day 2 and ending on Day 5.

Trial Locations (1)

66211

Quintiles Phase 1 Unit, Overland Park

Sponsors
All Listed Sponsors
lead

Tioga Pharmaceuticals

INDUSTRY

NCT01380561 - A Metabolite Identification, Mass Balance, and PK Study of [14C]-Asimadoline to Healthy Adult Male Volunteers | Biotech Hunter | Biotech Hunter